OPALEYE MANAGEMENT INC. – Neoleukin Therapeutics, Inc. Transaction History
OPALEYE MANAGEMENT INC. portfolio value:
$368,000
portfolio value
OPALEYE MANAGEMENT INC. quarter portfolio value change:
-37.86%
quarter
Neoleukin Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -5.74% | -35K shares | -260K | $0.64 | 575K |
| Q2 2022 | share | Decrease | -22.78% | -180K shares | -857K | $1.03 | 610K |
| Q1 2022 | share | Decrease | -24.57% | -257.3K shares | -3.56M | $1.88 | 790K |
| Q4 2021 | share | 0.00% | 0 shares | -2.52M | $5.1 | 1.04M | |
| Q3 2021 | share | Decrease | -9.42% | -108.9K shares | -3.1M | $7.23 | 1.04M |
| Q2 2021 | share | Decrease | -5.62% | -68.8K shares | -4.40M | $9.23 | 1.15M |
| Q1 2021 | share | Decrease | -11.64% | -161.3K shares | -4.46M | $12.31 | 1.22M |
| Q4 2020 | share | 0.00% | 0 shares | 2.91M | $14.1 | 1.38M | |
| Q3 2020 | share | Decrease | -0.98% | -13.7K shares | -6.60M | $12 | 1.38M |
| Q2 2020 | share | 0.00% | 0 shares | 7.30M | $16.6 | 1.4M | |
| Q1 2020 | share | Increase | +1.35% | 18.7K shares | -1.08M | $11.38 | 1.4M |
| Q4 2019 | share | Increase | +38.82% | 386.3K shares | 14.18M | $12.32 | 1.38M |
| Q3 2019 | share | Increase | 0.00% | 995K shares | 2.83M | $2.85 | 995K |